Showing 1 - 4 results of 4 for search 'Kristine Griffett', query time: 0.02s Refine Results
  1. 1
    Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases

    Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases by Kristine Griffett, Thomas P. Burris

    Published 2023-02-01
    Get full text
    Article
  2. 2
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.

    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis. by Monideepa Sengupta, Suomia Abuirqeba, Amina Kameric, Aurore Cecile-Valfort, Arindam Chatterjee, Kristine Griffett, Thomas P Burris, Colin A Flaveny

    Published 2021-01-01
    Get full text
    Article
  3. 3
    REV-ERB activation as a novel pharmacological approach for treating inflammatory pain

    REV-ERB activation as a novel pharmacological approach for treating inflammatory pain by Sangeet Makhija, Joshua D. Griffett, Giri Babu Veerakanellore, Giri Babu Veerakanellore, Thomas P. Burris, Bahaa Elgendy, Bahaa Elgendy, Kristine Griffett

    Published 2023-04-01
    Get full text
    Article
  4. 4
    Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH

    Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH by Ryan D. Welch, Cyrielle Billon, McKenna Losby, Gonzalo Bedia-Diaz, Yuanying Fang, Amer Avdagic, Bahaa Elgendy, Thomas P. Burris, Kristine Griffett

    Published 2022-03-01
    Get full text
    Article

Search Tools: